Major US drugmaker MSD is to pay up to $1.3 billion to acquire CN201, a novel investigational clinical-stage bispecific antibody for the treatment of B-cell associated...
Touchlight, a UK-based custom development and manufacturing organization (CDMO) specializing in enzymatic DNA production, signed a license agreement with British...
Santa Clara, CA-based Agilent Technologies has signed a definitive agreement to acquire specialized contract development and manufacturing organization Biovectra from H.I...
CordenPharma announced its largest strategic investment to date, committing to spend ~€900m over the next three years to enhance its peptide technology platform.
Ligand Pharmaceuticals recently announced that it has entered into a definitive agreement to acquire Apeiron Biologics AG, which holds royalty rights to Qarziba...
Bayer and Charité - Universitätsmedizin Berlin recently unveiled plans to establish the Berlin Center for Gene and Cell Therapies, a translational center for gene and...
Kyowa Kirin announced a new, state-of-the-art manufacturing facility in Sanford, North Carolina, US. Kyowa Kirin will invest up to $530 million (€489 million) in...
